Salsalate-induced changes in lipid, lipoprotein, and apoprotein concentrations in overweight or obese, insulin-resistant, nondiabetic individuals

Journal of Clinical Lipidology
Danit ArielGerald Reaven

Abstract

Although salsalate administration consistently lowers plasma triglyceride concentrations in patients with type II diabetes, prediabetes, and/or insulin resistance, changes in low-density lipoprotein cholesterol (LDL-C) concentrations have been inconsistent; varying from no change to a significant increase. To evaluate the clinical relevance of this discordance in more detail, we directly measured LDL-C and obtained a comprehensive assessment of changes in lipid, lipoprotein, and apoprotein concentrations associated with salsalate use in insulin-resistant individuals, overweight or obese, but without diabetes, using vertical auto profile method. A single-blind, randomized, placebo-controlled study was performed in volunteers who were overweight or obese, without diabetes, and insulin resistant on the basis of their steady-state plasma glucose concentration during an insulin suppression test. Participants were randomized 2:1 to receive salsalate 3.5 g/d (n = 27) or placebo (n = 14) for 4 weeks. Comprehensive lipid, lipoprotein, and apoprotein analysis by vertical auto profile was obtained after an overnight fast, before and after study intervention. There was no change in directly measured LDL-C concentration in salsalate-treated...Continue Reading

References

Sep 18, 1996·JAMA : the Journal of the American Medical Association·M J StampferC H Hennekens
Nov 18, 2006·Clinics in Laboratory Medicine·Krishnaji R Kulkarni
Apr 20, 2011·Circulation·Michael MillerUNKNOWN Council on the Kidney in Cardiovascular Disease
Sep 23, 2011·Acta Diabetologica·Elham FaghihimaniMasoud Amini
Mar 26, 2013·Journal of the American College of Cardiology·Seth S MartinSteven R Jones
Dec 20, 2014·Journal of Clinical Lipidology·Harold E BaysTerry A Jacobson

❮ Previous
Next ❯

Citations

Nov 26, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·S H Kim, G Reaven
Aug 27, 2018·Current Diabetes Reports·Mark A Yorek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.